GUANGYUYUAN

GuangYuYuan Chinese Herbal Medicine Co. secures a drug registration certificate for its subsidiary, expanding its pharmaceutical portfolio and driving future growth.

GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771) is a Xi’an‑based pharma firm with a diverse product range and a recent drug‑registration acquisition, offering stable but moderately volatile Shanghai Stock Exchange stock performance.

GuangYuYuan’s new drug registration boosts its pharma portfolio and investor confidence, marking a milestone for the Xi’an‑based Chinese herbal medicine firm.

GuangYuYuan: Xi’an‑based pharma leader blending Chinese and Western drugs, offering raw materials, tablets, injections, and advertising services.

GuangYuYuan’s 2025 stock rebound and diverse Chinese‑Western drug lineup illustrate its resilient growth, innovation, and high‑quality pharma standards.

GuangYuYuan Chinese Herbal Medicine Co., Ltd. is a prominent player in the pharmaceutical sector, known for its commitment to innovation, quality, and consumer engagement, with a strong financial foundation and strategic market positioning.